# Travere Therapeutics, Inc.: filings

TVTX · Nasdaq · CIK 1438533 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tvtx.md) · [Financials](/companies/tvtx/financials.md) · [Filings](/companies/tvtx/filings.md) · [Insiders](/companies/tvtx/insiders.md)

## Reports and events: 332 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 518, 8-K 209, 144 132, SC 13G/A 69, 10-Q 56, 3 30, SC 13G 26, SCHEDULE 13G/A 20, 10-K 18, 424B5 18, UPLOAD 16, CORRESP 14, CT ORDER 14, DEF 14A 14, S-8 13, 8-K/A 12, 10-Q/A 9, FWP 6, 10-K/A 5, SCHEDULE 13G 5, 305B2 3, ARS 3, DEFA14A 3, EFFECT 3, NT 10-Q 3, PRE 14A 3, S-3ASR 3, SC 13D/A 3, 10-12G/A 2, 4/A 2, DRS/A 2, S-1 2, S-1/A 2, SC 13D 2, 3/A 1, 424B1 1, 424B3 1, 5 1, 8-A12B 1, CERTNAS 1, D 1, DRS 1, NT 10-K 1, S-3 1, S-3/A 1, S-3MEF 1, SC 14F1 1, SC 14F1/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-21 | 20:10 ET | [8-K](/filings/0001438533-26-000068.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001438533-26-000068 |
| 2026-08-04 | 20:45 ET | [10-Q](/filings/0001438533-26-000063.md) | Quarterly report, period 2026-06-30 | 0001438533-26-000063 |
| 2026-08-04 | 20:05 ET | [8-K](/filings/0001438533-26-000062.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438533-26-000062 |
| 2026-07-09 | 21:10 ET | [8-K](/filings/0001438533-26-000054.md) | 5.02 Departure or appointment of officers or directors | 0001438533-26-000054 |
| 2026-06-16 | 20:34 ET | [8-K](/filings/0001438533-26-000048.md) | 5.02 Departure or appointment of officers or directors | 0001438533-26-000048 |
| 2026-06-02 | 11:05 ET | [8-K](/filings/0001193125-26-252474.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-252474 |
| 2026-05-21 | 20:07 ET | [8-K](/filings/0001438533-26-000046.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001438533-26-000046 |
| 2026-05-11 | 21:10 ET | [8-K](/filings/0001193125-26-217100.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-217100 |
| 2026-05-04 | 20:45 ET | [10-Q](/filings/0001438533-26-000042.md) | Quarterly report, period 2026-03-31 | 0001438533-26-000042 |
| 2026-05-04 | 20:05 ET | [8-K](/filings/0001438533-26-000041.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438533-26-000041 |
| 2026-04-14 | 00:44 ET | [8-K](/filings/0001438533-26-000032.md) | 8.01 Other events | 0001438533-26-000032 |
| 2026-04-06 | 20:07 ET | [DEF 14A](/filings/0001438533-26-000027.md) | Proxy statement, period 2026-05-19 | 0001438533-26-000027 |
| 2026-02-19 | 21:47 ET | [10-K](/filings/0001438533-26-000014.md) | Annual report, period 2025-12-31 | 0001438533-26-000014 |
| 2026-02-19 | 21:05 ET | [8-K](/filings/0001438533-26-000013.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438533-26-000013 |
| 2026-01-13 | 21:32 ET | [8-K](/filings/0001438533-26-000005.md) | 8.01 Other events | 0001438533-26-000005 |
| 2026-01-12 | 22:04 ET | [8-K](/filings/0001438533-26-000003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438533-26-000003 |
| 2025-10-30 | 20:46 ET | [10-Q](/filings/0001438533-25-000056.md) | Quarterly report, period 2025-09-30 | 0001438533-25-000056 |
| 2025-10-30 | 20:06 ET | [8-K](/filings/0001438533-25-000055.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438533-25-000055 |
| 2025-09-10 | 11:05 ET | [8-K](/filings/0001438533-25-000049.md) | 8.01 Other events | 0001438533-25-000049 |
| 2025-08-06 | 21:16 ET | [10-Q](/filings/0001438533-25-000046.md) | Quarterly report, period 2025-06-30 | 0001438533-25-000046 |
| 2025-08-06 | 20:06 ET | [8-K](/filings/0001438533-25-000045.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438533-25-000045 |
| 2025-05-16 | 20:13 ET | [8-K](/filings/0001438533-25-000034.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001438533-25-000034 |
| 2025-05-15 | 20:29 ET | [8-K](/filings/0001438533-25-000032.md) | 8.01 Other events | 0001438533-25-000032 |
| 2025-05-01 | 21:21 ET | [8-K/A](/filings/0001438533-25-000030.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438533-25-000030 |
| 2025-05-01 | 20:47 ET | [10-Q](/filings/0001438533-25-000026.md) | Quarterly report, period 2025-03-31 | 0001438533-25-000026 |
| 2025-05-01 | 20:05 ET | [8-K](/filings/0001438533-25-000025.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001438533-25-000025 |
| 2025-04-30 | 21:54 ET | [8-K](/filings/0001438533-25-000020.md) | 8.01 Other events | 0001438533-25-000020 |
| 2025-04-01 | 20:06 ET | [DEF 14A](/filings/0001438533-25-000016.md) | Proxy statement, period 2025-05-15 | 0001438533-25-000016 |
| 2025-03-17 | 20:57 ET | [8-K](/filings/0001438533-25-000012.md) | 8.01 Other events | 0001438533-25-000012 |
| 2025-02-21 | 01:36 ET | [10-K](/filings/0001438533-25-000010.md) | Annual report, period 2024-12-31 | 0001438533-25-000010 |
| 2025-02-20 | 21:04 ET | [8-K](/filings/0001438533-25-000008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438533-25-000008 |
| 2025-02-11 | 12:05 ET | [8-K](/filings/0001438533-25-000004.md) | 8.01 Other events | 0001438533-25-000004 |
| 2025-01-13 | 12:30 ET | [8-K](/filings/0001438533-25-000002.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438533-25-000002 |
| 2024-11-08 | 21:13 ET | [8-K](/filings/0001193125-24-254153.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-254153 |
| 2024-10-31 | 12:36 ET | [10-Q](/filings/0001438533-24-000048.md) | Quarterly report, period 2024-09-30 | 0001438533-24-000048 |
| 2024-10-31 | 12:05 ET | [8-K](/filings/0001438533-24-000046.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438533-24-000046 |
| 2024-09-26 | 20:02 ET | [8-K](/filings/0001438533-24-000038.md) | 8.01 Other events | 0001438533-24-000038 |
| 2024-09-06 | 21:47 ET | [8-K](/filings/0001438533-24-000035.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001438533-24-000035 |
| 2024-08-01 | 20:40 ET | [10-Q](/filings/0001438533-24-000031.md) | Quarterly report, period 2024-06-30 | 0001438533-24-000031 |
| 2024-08-01 | 20:05 ET | [8-K](/filings/0001438533-24-000030.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438533-24-000030 |
| 2024-05-13 | 20:05 ET | [8-K](/filings/0001438533-24-000022.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001438533-24-000022 |
| 2024-05-06 | 20:46 ET | [10-Q](/filings/0001438533-24-000020.md) | Quarterly report, period 2024-03-31 | 0001438533-24-000020 |
| 2024-05-06 | 20:05 ET | [8-K](/filings/0001438533-24-000019.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438533-24-000019 |
| 2024-04-24 | 20:05 ET | [8-K](/filings/0001438533-24-000016.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001438533-24-000016 |
| 2024-03-27 | 20:31 ET | [DEF 14A](/filings/0001438533-24-000012.md) | Proxy statement, period 2024-05-08 | 0001438533-24-000012 |
| 2024-02-23 | 21:05 ET | [8-K](/filings/0001438533-24-000007.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001438533-24-000007 |
| 2024-02-20 | 13:10 ET | [10-K](/filings/0001438533-24-000005.md) | Annual report, period 2023-12-31 | 0001438533-24-000005 |
| 2024-02-15 | 21:05 ET | [8-K](/filings/0001438533-24-000003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001438533-24-000003 |
| 2024-01-08 | 12:07 ET | [8-K](/filings/0001193125-24-003866.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-003866 |
| 2023-12-04 | 21:10 ET | [8-K](/filings/0001438533-23-000050.md) | 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0001438533-23-000050 |

Page 1 of 7. [Older](/companies/tvtx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.